Filing Details
- Accession Number:
- 0001209191-22-051033
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-22 17:13:30
- Reporting Period:
- 2022-09-20
- Accepted Time:
- 2022-09-22 17:13:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1652724 | Lucira Health Inc. | LHDX | In Vitro & In Vivo Diagnostic Substances (2835) | 272491037 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1882773 | Joseph Anthony Allen | C/O Lucira Health Inc. 1412 62Nd St. Emeryville CA 94608 | Chief Operations Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-09-20 | 17,052 | $1.39 | 183,617 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Unitsgranted on September 30, 2021 for 197,240 shares.
- Includes 3,429 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on August 19, 2022, respectively.
Billionaire Hedge Funds
